|
VIPPS 17-Point Criteria
Licensure
Criteria Number 1:
Qualifying VIPPS
Pharmacies will provide NABP with the information necessary to verify that
all persons affiliated with the site, including those affiliated through
contractual or other responsible arrangements, that are engaging in the
practice of pharmacy are appropriately licensed or registered and in good
standing in all applicable jurisdictions.
Are all persons affiliated
with this site through contractual or other responsible arrangement and
who are engaging in the practice of pharmacy (including pharmacists and
technicians) appropriately licensed or registered in good standing in the
state in which they practice?
Criteria Number 2:
Agree to
comply with all applicable statutes and regulations governing the practice
of pharmacy where licensed or registered. When a conflict arises between
individual state laws or regulations, or between state and federal laws or
regulations, the VIPPS Pharmacy will agree to comply with the more
stringent law or regulation that applies as determined by conflict-of-law
rules.
Prescription
Criteria Number 3:
Maintain and enforce policies and procedures that assure the
integrity, legitimacy, and authenticity of the Prescription Drug Order and
seek to prevent Prescription Drug Orders from being submitted, honored,
and filled by multiple pharmacies.
Criteria Number 4:
Maintain and enforce policies and procedures that assure compliance
with applicable generic substitution statutes and regulations and prohibit
unauthorized therapeutic substitution from occurring without the necessary
patient or prescriber authorization and outside of the conditions for
participation in state or federal programs, such as Medicaid.
Patient
Criteria
Number 5:
Maintain and enforce policies and procedures ensuring
reasonable verification of the identity of the patient, prescriber, and,
if appropriate, caregiver, in accordance with applicable state
law.
Criteria Number 6:
Obtain and maintain in a readily
accessible format, patient medication profiles and other related data in a
manner that facilitates consultation with the prescriber, when applicable,
and counseling of the patient or caregiver.
Criteria Number 7:
Conduct a prospective drug use review (DUR) prior to the dispensing of
a medication or device in accordance with applicable state
law.
Criteria Number 8:
Maintain and enforce policies and
procedures to assure patient confidentiality and protect patient identity
and patient-specific information from inappropriate or non-essential
access, use, or distribution. [The NABP Guidelines for the
Confidentiality of Patient Health Care Information as It Relates to
Patient Compliance and Patient Intervention Programs can serve as a
useful resource for addressing the confidentiality and security of patient
data.]
Communication
Criteria Number 9:
Maintain and enforce policies and procedures requiring pharmacists to
offer interactive, meaningful consultation to the patient or
caregiver.
Criteria Number 10:
Maintain and enforce policies
and procedures establishing a mechanism for patients to report, and the
VIPPS Pharmacy to take appropriate action regarding, suspected adverse
drug reactions and errors.
Criteria Number 11:
Maintain and
enforce policies and procedures that provide a mechanism to contact the
patient and, if necessary, the prescriber, if an undue delay is
encountered in delivering the prescribed drug or device. Undue delay is
defined as an extension of the normal delivery cycle sufficient to
jeopardize or alter the patient treatment plan.
Criteria Number
12:
Maintain and enforce policies and procedures establishing
mechanisms to inform patients or caregivers about drug recalls and to
educate patients and caregivers about the appropriate means to dispose of
expired, damaged, and unusable medications.
Storage and
Shipment
Criteria Number 13:
Ship controlled
substances to patients via a secure and traceable means.
Criteria
Number 14:
Assure that medications and devices are maintained
within appropriate temperature, light, and humidity standards, as
established by the United States Pharmacopoeia (USP), during storage and
shipment.
Over-the-Counter
Criteria Number 15:
Comply with all applicable federal and state laws regarding the sale
of Over-the-Counter Products identified as precursors to the manufacture
or compounding of illegal drugs.
QA/QI Program
Criteria Number 16:
Maintain a Quality
Assurance/Quality Improvement Program.
Criteria Number 17:
Notify NABP within 30 days of any change of information provided as
part of the verification process or involving data displayed on the VIPPS
Web site.
Notify NABP of any change of the
Pharmacist-in-Charge.
TOP
Comments? Click here. |
|